دورية أكاديمية
A phase 2 multicenter study of tivantinib (ARQ 197) monotherapy in patients with relapsed or refractory germ cell tumors
| العنوان: | A phase 2 multicenter study of tivantinib (ARQ 197) monotherapy in patients with relapsed or refractory germ cell tumors |
|---|---|
| المؤلفون: | Feldman, Darren R., Einhorn, Lawrence H., Quinn, David I., Loriot, Yohann, Joffe, Johnathan K., Vaughn, David J., Fléchon, Aude, Hajdenberg, Julio, Halim, Abdel-Baset, Zahir, Hamim, Motzer, Robert J. |
| المصدر: | Investigational New Drugs: The Journal of New Anticancer Agents. August 2013 31(4):1016-1022 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 01676997 15730646 |
|---|---|
| DOI: | 10.1007/s10637-013-9934-y |